Twinbeech Capital LP Dexcom Inc Transaction History

Twinbeech Capital LP

$4.99 Billion
Q3 2024

A detailed history of Twinbeech Capital LP transactions in Dexcom Inc stock. As of the latest transaction made, Twinbeech Capital LP holds 62,839 shares of DXCM stock, worth $5.03 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

62,839

Previous 329,682 80.94%

Holding current value

$5.03 Million

Previous $37.4 Million 88.73%

% of portfolio

0.08%

Previous 0.76%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $17.1 Million - $31 Million	-266,843 Reduced 80.94%	62,839 $4.21 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $36.4 Million - $46.3 Million	329,682 New	329,682 $37.4 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $21.3 Million - $34.2 Million	247,715 New	247,715 $23.1 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $5.78 Million - $6.83 Million	55,558 Added 23.7%	289,965 $33.7 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $19.9 Million - $28.8 Million	234,407 New	234,407 $26.5 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $3.81 Million - $5.27 Million	-40,447 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $5.25 Million - $6.59 Million	40,447 New	40,447 $21.7 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $85,039 - $113,326	-1,050 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $89,029 - $109,977	1,050 New	1,050 $377,000
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $827,292 - $1.31 Million	-17,311 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $633,928 - $991,747	17,311 New	17,311 $3.79 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Account

Twinbeech Capital LP Dexcom Inc Transaction History